MedTech Dive June 10, 2024
Johnson & Johnson has identified Velys as a product that can help it regain market share from rivals such as Stryker.
Dive Brief:
- Johnson & Johnson received 510(k) clearance for its Velys surgical robot for use in partial knee replacement procedures, the company said Thursday
- J&J sees robotics as a way to overcome surgical challenges that it believes are limiting the use of partial knee replacement, despite the potential for the procedure to shorten recovery times.
- The company, which received clearance for its robot in total knee procedures in 2021, has identified Velys as a product that can help it regain market share from rivals such as Stryker.
Dive Insight:
Stryker established a lead over J&J in...
Today's Sponsors
Today's Sponsor